Mitochondrial function determines severity but not risk of amyotrophic lateral sclerosis
Harvey, C.; Weinreich, M.; Zhang, S.; Hop, P. J.; Zwamborn, R. A.; van Eijk, K. R.; Julian, T. H.; Moll, T.; Iacoangeli, A. R.; Al-Khleifat, A.; Quinn, J. P.; Pfaff, A. L.; Koks, S.; Poulton, J.; Battle, S. L.; Arking, D.; Snyder, M.; Project MinE ALS Sequencing Consortium, ; Veldink, J.; Kenna, K. P.; Shaw, P. J.; Cooper-Knock, J.
Show abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Selective vulnerability of energy-intensive motor neurons (MNs) has fostered speculation that mitochondrial function is a determinant of ALS. Previously, the position of mitochondrial function in the pathogenic cascade leading to neurotoxicity has been unclear. We separated upstream genetic determinants of mitochondrial function, including genetic variation within the mitochondrial genome or autosomes; from downstream changeable factors including mitochondrial copy number (mtCN) and MN gene expression. We discovered that functionally validated mitochondrial haplotypes are a determinant of ALS survival but not ALS risk. Loss-of-function genetic variants within, and reduced MN expression of, ACADM and DNA2 lead to shorter ALS survival; both genes impact mitochondrial function. MtCN responds dynamically to the onset of ALS independent of mitochondrial haplotype, and is also significantly correlated with disease severity. We conclude that mitochondrial function impacts ALS progression but not risk; our findings have therapeutic implications.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Specific heterozygous frameshift variants in hnRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy 93%
- Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome Sequencing 93%
- Mitochondrial complex I deficiency stratifies idiopathic Parkinson's disease 93%
Similar papers in this journal
- The oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling, and therapeutic implications 95%
- Spinal Cord Motor Neuron Phenotypes and Polygenic Risk Scores in Sporadic Amyotrophic Lateral Sclerosis: Deciphering the Disease Pathology and Therapeutic Potential of Ropinirole Hydrochloride 92%
- Parkinsons disease determinants, prediction and gene-environment interactions in the UK Biobank 91%
Similar papers in this journal
- Single-cell transcriptomic landscape of the neuroimmune compartment in amyotrophic lateral sclerosis brain and spinal cord 96%
- Nuclear depletion of RNA binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis 96%
- TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy 93%
Similar papers in this journal
Similar papers in this journal
- Gene co-expression network analysis in human spinal cord highlights mechanisms underlying amyotrophic lateral sclerosis susceptibility 96%
- Modeling of mitochondrial genetic polymorphisms reveals induction of heteroplasmy by pleiotropic disease locus MT:10398A>G 94%
- Disrupted copper availability in sporadic ALS: Implications for CuII(atsm) as a treatment option 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.